T
JAZZ icon

Transce3nd’s Jazz Pharmaceuticals JAZZ Stock Holding History

Transce3nd’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-78
Closed -$8.28K – 684
2025
Q2 		$8.28K Hold
78
– – ﹤0.01% 623
2025
Q1 		$9.68K Hold
78
– – ﹤0.01% 569
2024
Q4 		$9.61K Buy
+78
New +$9.19K ﹤0.01% 765

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Transce3nd's JAZZ Position: Q3 2025 in Review

Transce3nd sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 78 shares — an estimated $8.28K sold.

Transce3nd first reported a position in JAZZ in Q4 2024 and held it in 3 quarters. The position peaked at $9.68K in Q1 2025. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Transce3nd reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Transce3nd sold 78 Jazz Pharmaceuticals shares in Q3 2025, an estimated $8.28K.
  • Transce3nd first reported a position in Jazz Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Transce3nd's Jazz Pharmaceuticals position peaked at $9.68K in Q1 2025.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.